Abstract:Photodynamic therapy (PDT), a clinically approved cancer treatment, has faced many drawbacks that restricted its applications. For example, the hypoxia-induced elevated hypoxia-inducible factor-1 alpha (HIF-1 alpha) may desensitize tumors to PDT, and the high concentration of glutathione (GSH) in cancer cells can also neutralize the generated reactive oxygen species (ROS) during PDT, resulting in insufficient therapy. Moreover, extra probes for imaging-guided visualization therapy are always needed to track drug release or distribution, while it may decrease the drug loading of the drug delivery system (DDS). In the present study, we have designed and prepared a novel multifunctional combined therapy nanoparticle (ZnPc@Cur-S-OA NPs), in which curcumin (Cur) was not only used as a chemotherapy drug to achieve a combination therapy with PDT via downregulating HIF-1 alpha and depleting GSH in B16F10 cells but also designed as a small-molecule ROS-triggered release prodrug to deliver the photosensitizer (PS). The red fluorescence of PS in the nanoparticles (NPs) can be used to track the NPs distribution, while the green fluorescence of Cur showed an "OFF-ON" activation, which enables additional imaging and real-time self-monitoring capabilities. These results proved that the prepared combined therapy NPs were more effective to inhibit the growth of B16F10 mouse melanoma tumor than was monotherapy without eliciting systemic toxicity either in vitro or in vivo, which indicated the combined therapy NPs as an effective way to improve the PDT efficacy via downregulation of HIF-1 alpha and depletion of GSH. Thus, the strategy of using a multifunctional natural product as the stimuli-responsive carrier as well as the synergist with PDT for enhancing antitumor efficacy via multiple pathways may open an alternative avenue to fabricate new self-delivery combination therapy nanodrugs. Besides, the fluorescence emitted from the drug can be used for real-time self-monitoring of drug release and distribution, which has great potential in clinic to adjust the administration dose and irradiation time for different tumor types and stages for individual therapy.

Jointly Depleting Glutathione based on Self‐assembled Nanomicelles for Enhancing Photodynamic Therapy

Molecularly Engineering a Dual-Drug Nanoassembly for Self-Sensitized Photodynamic Therapy Via Thioredoxin Impairment and Glutathione Depletion

A ROS Responsive Nanomedicine with Enhanced Photodynamic Therapy Via Dual Mechanisms: GSH Depletion and Biosynthesis Inhibition.

Three Birds with One Stone: A Ferric Pyrophosphate Based Nanoagent for Synergetic NIR-triggered Photo/chemodynamic Therapy with Glutathione Depletion

Glutathione-induced Amino-Activatable Micellar Photosensitization Platform for Synergistic Redox Modulation and Photodynamic Therapy

Dextran-based Nanodrugs with Mitochondrial Targeting/glutathione Depleting Synergy for Enhanced Photodynamic Therapy

Pre-drug Self-assembled Nanoparticles: Recovering Activity and Overcoming Glutathione-Associated Cell Antioxidant Resistance Against Photodynamic Therapy.

Modulation of Glutathione Levels by Redox‐Active Nanogel Carriers for the Synergistic Enhancement of Photodynamic Therapy

Mitochondria-targeted Photosensitizer Based Nanoplatform Loading Glutathione Inhibitor for Enhanced Breast Cancer Photodynamic Therapy

Self-delivered and Self-monitored Chemo-Photodynamic Nanoparticles with Light-triggered Synergistic Anti-tumor Therapies by Downgrading HIF-1α and Depleting GSH.

Self-Delivered and Self-Monitored Chemo-Photodynamic Nanoparticles with Light-Triggered Synergistic Antitumor Therapies by Downregulation of HIF-1 and Depletion of GSH

Enhanced Photodynamic Therapy Based on an Amphiphilic Branched Copolymer with Pendant Vinyl Groups for Simultaneous GSH Depletion and Ce6 Release.

Open-Source and Reduced-Expenditure Nanosystem with ROS Self-Amplification and Glutathione Depletion for Simultaneous Augmented Chemodynamic/Photodynamic Therapy

Enhanced Photodynamic Therapy by Reduced Levels of Intracellular Glutathione Obtained by Employing a Nano‐MOF with CuII As the Active Center

A GSH-responsive Nanophotosensitizer for Efficient Photodynamic Therapy

Glutathione-depleting Polyprodrug Nanoparticle for Enhanced Photodynamic Therapy and Cascaded Locoregional Chemotherapy

Enhancement of Ultralow-Intensity NIR Light-Triggered Photodynamic Therapy Based on Exo- and Endogenous Synergistic Effects Through Combined Glutathione-Depletion Chemotherapy.

Improved Photodynamic Therapy Based on Glutaminase Blockage via Tumor Membrane Coated CB‐839/IR‐780 Nanoparticles

An Intelligent Triple Assisted Gold Cluster‐Based Nanosystem for Enhanced Tumor Photodynamic Therapy

Metal–organic framework derived multicomponent nanoagent as a reactive oxygen species amplifier for enhanced photodynamic therapy

Tumor-specific carrier-free nanodrugs with GSH depletion and enhanced ROS generation for endogenous synergistic anti-tumor by a chemotherapy-photodynamic therapy